Year |
Citation |
Score |
2023 |
Rogers JP, Chou MKL, Pollak TA, Eyre M, Krutikov M, Church A, Hart MS, Karim A, Michael S, Vincent A, David AS, Lewis G, Jacob S, Zandi MS. Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results. Journal of Neurology. PMID 37737893 DOI: 10.1007/s00415-023-11917-6 |
0.441 |
|
2021 |
Benjamin LA, Paterson RW, Moll R, Pericleous C, Brown R, Mehta PR, Athauda D, Ziff OJ, Heaney J, Checkley AM, Houlihan CF, Chou M, Heslegrave AJ, Chandratheva A, Michael BD, ... ... Zandi MS, et al. Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study. Eclinicalmedicine. 101070. PMID 34401683 DOI: 10.1016/j.eclinm.2021.101070 |
0.323 |
|
2021 |
Karunaratne K, Ahrabian D, Monoghan B, Campion T, Yousry T, Lunn MP, Zandi MS, Howard RS, Kullmann DM, Spillane J, Walker M, Chataway J. Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis. Bmj Neurology Open. 3: e000096. PMID 34079936 DOI: 10.1136/bmjno-2020-000096 |
0.354 |
|
2021 |
Abrol E, Coutinho E, Chou M, Hart M, Vincent A, Howard R, Zandi MS, Isenberg D. Psychosis in Systemic Lupus Erythematosus (SLE): 40-year experience of a specialist centre. Rheumatology (Oxford, England). PMID 33629101 DOI: 10.1093/rheumatology/keab160 |
0.356 |
|
2020 |
Varley JA, Andersson M, Grant E, Berretta A, Zandi MS, Bondet V, Duffy D, Hunt D, Piehl F, Waters P, Irani SR. Absence of neuronal autoantibodies in neuropsychiatric systemic lupus erythematosus. Annals of Neurology. PMID 32951275 DOI: 10.1002/Ana.25908 |
0.348 |
|
2020 |
Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L, Vivekanandam V, Khoo A, Geraldes R, Chinthapalli K, Boyd E, ... ... Zandi MS, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain : a Journal of Neurology. PMID 32637987 DOI: 10.1093/Brain/Awaa240 |
0.479 |
|
2020 |
Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L, Vivekanandam V, Khoo A, Geraldes R, Chinthapalli K, Boyd E, ... ... Zandi MS, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain : a Journal of Neurology. PMID 32637987 DOI: 10.1093/Brain/Awaa240 |
0.479 |
|
2020 |
Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, Al-Shahi Salman R, Menon DK, Nicholson TR, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet. Psychiatry. PMID 32593341 DOI: 10.1016/S2215-0366(20)30287-X |
0.324 |
|
2020 |
Ellul M, Varatharaj A, Nicholson TR, Pollak TA, Thomas N, Easton A, Zandi MS, Manji H, Solomon T, Carson A, Turner MR, Kneen R, Galea I, Pett S, Thomas RH, et al. Defining causality in COVID-19 and neurological disorders. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32503883 DOI: 10.1136/Jnnp-2020-323667 |
0.376 |
|
2020 |
Varatharaj A, Thomas N, Ellul M, Davies NW, Pollak T, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, Salman RA, Menon D, Nicholson T, et al. UK-Wide Surveillance of Neurological and Neuropsychiatric Complications of COVID-19: The First 153 Patients The Lancet Psychiatry. DOI: 10.2139/Ssrn.3601761 |
0.363 |
|
2019 |
Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu LM, Tomei G, Pollard R, Vincent SA, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, et al. Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2). Trials. 20: 331. PMID 31174586 DOI: 10.1186/S13063-019-3336-1 |
0.419 |
|
2019 |
Bharucha T, Brown R, Bamford A, Kaliakatsos M, Hoskote C, Breuer J, Manji H, Zandi M. P58 Setting up an encephalitis multidisciplinary meeting in a tertiary neurology centre Journal of Neurology, Neurosurgery & Psychiatry. 90: e38.4-e39. DOI: 10.1136/Jnnp-2019-Abn.123 |
0.311 |
|
2019 |
Brown R, Spillane J, Lunn M, Radcliffe J, Zandi M, Kullmann D, Howard R. 061 Management of NMDA-receptor encephalitis on the neurological ICU Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.80 |
0.373 |
|
2019 |
Brown R, Au L, Spain L, Furness A, Rees J, Rossor A, Morris E, Zandi M, Lunn M, Larkin J, Turajlic S, Carr A. 208 Immune checkpoint inhibitor-related neurotoxicity: a case series Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.176 |
0.409 |
|
2018 |
Keddie S, Crisp SJ, Blackaby J, Cox A, Coles A, Hart M, Church AJ, Vincent A, Zandi M, Lunn MP. Plasma cell depletion with bortezomib in the treatment of refractory NMDAR-antibody encephalitis. Rational developments in neuroimmunological treatment. European Journal of Neurology. PMID 30035842 DOI: 10.1111/Ene.13759 |
0.508 |
|
2018 |
Lennox BR, Tomei G, Vincent SA, Yeeles K, Pollard R, Palmer-Cooper E, Jones P, Zandi MS, Coles A. Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1). Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29891740 DOI: 10.1136/Jnnp-2018-318124 |
0.502 |
|
2017 |
Tam J, Zandi MS. The witchcraft of encephalitis in Salem. Journal of Neurology. PMID 28631128 DOI: 10.1007/S00415-017-8546-4 |
0.31 |
|
2016 |
Zandi MS. Autoimmune Encephalitis. Focus (American Psychiatric Publishing). 14: 432-436. PMID 31975823 DOI: 10.1176/appi.focus.20160019 |
0.372 |
|
2015 |
Zandi MS, Lennox BR, Vincent A. The Importance of Keeping in Mind the Diagnosis of N-Methyl-D-Aspartate Receptor Encephalitis. Biological Psychiatry. PMID 26742924 DOI: 10.1016/J.Biopsych.2015.08.038 |
0.566 |
|
2015 |
Zandi MS, Lennox B, Vincent A. N-Methyl-D-Aspartate Receptor Autoantibodies in Psychiatric Illness. Biological Psychiatry. PMID 26185011 DOI: 10.1016/J.Biopsych.2015.03.034 |
0.51 |
|
2015 |
Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL, Cox AL, Lennox B, Stamelou M, Bhatia KP, Schott JM, Coles AJ, Kullmann DM, Vincent A. Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 708-13. PMID 25246644 DOI: 10.1136/Jnnp-2014-308736 |
0.562 |
|
2014 |
Zandi MS, Deakin JB, Morris K, Buckley C, Jacobson L, Scoriels L, Cox AL, Coles AJ, Jones PB, Vincent A, Lennox BR. Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series. Schizophrenia Research. 160: 193-5. PMID 25468187 DOI: 10.1016/J.Schres.2014.11.001 |
0.582 |
|
2014 |
Needham E, Zandi MS. Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia. Journal of Neurology. 261: 2037-42. PMID 25182699 DOI: 10.1007/S00415-014-7473-X |
0.342 |
|
2014 |
Brown JW, Martin PJ, Thorpe JW, Michell AW, Coles AJ, Cox AL, Vincent A, Zandi MS. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. Journal of Neuroimmunology. 271: 66-8. PMID 24703099 DOI: 10.1016/J.Jneuroim.2014.03.012 |
0.501 |
|
2014 |
Deakin J, Lennox BR, Zandi MS. Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis. Biological Psychiatry. 75: 284-91. PMID 23988024 DOI: 10.1016/J.Biopsych.2013.07.018 |
0.446 |
|
2014 |
Paterson RW, Zandi MS, Armstrong R, Vincent A, Schott JM. Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 625-30. PMID 23757422 DOI: 10.1136/Jnnp-2013-305218 |
0.528 |
|
2014 |
Lennox B, Zandi MS, Deakin JB, Coles A, Scoriels L, Jones P, Coutinho E, Vincent A. NMDA RECEPTOR ANTIBODIES IN FIRST EPISODE PSYCHOSIS: PREVALENCE AND CLINICAL PHENOTYPE Schizophrenia Research. 153: S35. DOI: 10.1016/S0920-9964(14)70116-1 |
0.533 |
|
2013 |
Zandi MS. Defining and treating leucine-rich glioma inactivated 1 antibody associated autoimmunity. Brain : a Journal of Neurology. 136: 2933-5. PMID 24072484 DOI: 10.1093/Brain/Awt256 |
0.349 |
|
2011 |
Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, Coles AJ, Vincent A, Lennox BR. Disease-relevant autoantibodies in first episode schizophrenia. Journal of Neurology. 258: 686-8. PMID 20972895 DOI: 10.1007/S00415-010-5788-9 |
0.561 |
|
2010 |
Somerfield J, Hill-Cawthorne GA, Lin A, Zandi MS, McCarthy C, Jones JL, Willcox M, Shaw D, Thompson SA, Compston AS, Hale G, Waldmann H, Coles AJ. A novel strategy to reduce the immunogenicity of biological therapies. Journal of Immunology (Baltimore, Md. : 1950). 185: 763-8. PMID 20519651 DOI: 10.4049/Jimmunol.1000422 |
0.496 |
|
2010 |
Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain : a Journal of Neurology. 133: 1655-67. PMID 20511282 DOI: 10.1093/Brain/Awq113 |
0.69 |
|
2009 |
Zandi MS, Irani SR, Follows G, Moody AM, Molyneux P, Vincent A. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology. 73: 2039-40. PMID 19996080 DOI: 10.1212/Wnl.0B013E3181C55E9B |
0.524 |
|
Show low-probability matches. |